1. Preoperative Endoscopic Retrograde Cholangiopancreatography Is Not Associated With Increased Pancreatic Cancer Mortality 
Sheila D. Rustgi, Sunil Amin, Anthony Yang, Michelle K. Kim, Satish Nagula, Nikhil A. Kumta, Christopher J. DiMaio, Paolo Boffetta, Aimee L. Lucas 
Clinical Gastroenterology and Hepatology 
Volume 17, Issue 8, Pages e4 (July 2019)
DOI: /j.cgh
Copyright © 2019 AGA Institute Terms and Conditions

2. Figure 1
Patient cohort selection. ERCP, endoscopic retrograde cholangiopancreatography; ICD-O-2, International Classification of Diseases for Oncology, 2nd ed; PDAC, pancreatic ductal adenocarcinoma.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2019 AGA Institute Terms and Conditions

3. Figure 2
Kaplan–Meier curve of patients receiving preoperative ERCP vs no preoperative ERCP. Survival was 18.8 months for those who underwent preoperative ERCP compared with 18.5 months for those who did not receive preoperative ERCP (P = .22). ERCP, endoscopic retrograde cholangiopancreatography.
Clinical Gastroenterology and Hepatology  , e4DOI: ( /j.cgh )
Copyright © 2019 AGA Institute Terms and Conditions